Core Viewpoint - Changfeng Pharmaceutical (02652) has announced a proposal to adopt a H-share incentive trust plan for 2025, aimed at aligning the interests of employees, management, and shareholders, while attracting, retaining, and motivating key talent to drive the company's sustainable development and long-term success [1] Summary by Relevant Categories - **Incentive Plan** - The H-share incentive plan is designed to align the interests of employees, management, and shareholders [1] - The plan aims to attract, retain, and motivate key talent within the company [1] - It is intended to reward contributions from employees and management, promoting the company's ongoing development [1] - **Long-term Strategy** - The initiative is part of the company's strategy to ensure sustainable growth and long-term success [1] - By implementing this plan, the company seeks to enhance its competitive position in the industry [1]

Core Viewpoint - Changfeng Pharmaceutical (02652.HK) has announced the adoption of the H-share incentive trust plan aimed at aligning the interests of employees, management, and shareholders, thereby attracting, retaining, and motivating key talents to drive the company's sustainable development and long-term success [1] Group 1 - The H-share incentive plan is set to be implemented on November 12, 2025 [1] - The primary goal of the plan is to ensure the alignment of interests among employees, management, and shareholders [1] - The initiative is designed to attract, retain, and motivate key talents while rewarding their contributions [1]